Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: United States Clear all

179 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20023
20039
20042
20056
20064
200711
20088
200914
20107
20121
20139
20147
20157
20169
20175
20188
20195
20208
20219
20228
20233
20245
202512
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed101
Terminated44
Recruiting16
Active, not recruiting12
Unknown status4
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
Hoffmann-La Roche14
Otsuka Pharmaceutical Development & Commercialization, Inc.11
Pfizer9
National Institute on Aging (NIA)8
Bristol-Myers Squibb6
Avid Radiopharmaceuticals5
GE Healthcare5
Axsome Therapeutics, Inc.4
Biogen4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease179
Dementia44
Cognitive Dysfunction23
Psychomotor Agitation22
Neurodegenerative Diseases10
Mental Disorders8
Nervous System Diseases8
Brain Diseases7
Memory Disorders7
Amyloid Neuropathies, Familial6

Trials

Showing 1 to 25 of 179. Each trial links to its page on Pharma Observatory.

79 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.